Krystal Biotech Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 23, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	6,815	4,352	3,166	1,909	1,532	967
Market Cap Growth	66.50%	37.47%	65.87%	24.59%	58.47%	13.17%
Enterprise Value	6,096	3,689	2,632	1,536	1,220	735
Last Close Price	237.50	151.35	115.00	73.50	62.00	-
PE Ratio	40.20	50.54	320.10	-	-	-
PS Ratio	21.43	15.51	69.02	-	-	-
PB Ratio	7.03	4.76	4.49	3.91	2.94	4.05
P/TBV Ratio	7.03	4.76	4.49	3.91	2.94	4.05
P/FCF Ratio	48.29	37.81	-	-	-	-
P/OCF Ratio	45.38	36.51	-	-	-	-
EV/Sales Ratio	19.41	13.15	57.38	-	-	-
EV/EBITDA Ratio	44.93	36.14	-	-	-	-
EV/EBIT Ratio	45.74	37.01	-	-	-	-
EV/FCF Ratio	43.19	32.04	-	-	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.02	0.01	0.01
Debt / EBITDA Ratio	0.06	0.07	-	-	-	-
Debt / FCF Ratio	0.06	0.06	-	-	-	-
Asset Turnover	0.34	0.31	0.07	-	-	-
Inventory Turnover	0.76	1.20	-	-	-	-
Quick Ratio	9.43	6.89	17.35	13.14	17.02	17.56
Current Ratio	10.14	7.28	17.77	13.30	17.18	17.80
Return on Equity (ROE)	19.66%	10.34%	1.68%	-25.09%	-15.71%	-13.00%
Return on Assets (ROA)	8.91%	6.88%	-8.83%	-12.80%	-9.32%	-7.93%
Return on Invested Capital (ROIC)	40.36%	31.60%	-40.54%	-76.89%	-74.23%	-177.13%
Return on Capital Employed (ROCE)	13.80%	10.80%	-12.40%	-22.90%	-11.60%	-11.20%
Earnings Yield	2.49%	1.98%	0.31%	-6.86%	-3.99%	-2.72%
FCF Yield	2.07%	2.65%	-2.88%	-7.53%	-6.67%	-3.46%
Buyback Yield / Dilution	-1.34%	-7.16%	-8.87%	-14.85%	-18.15%	-18.15%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.